“…Although MET PET has been suggested to have high sensitivity (76%–100%) and specificity (75%–100%) for untreated brain tumors, nontumor lesions have been reported to be associated with increased MET uptake 1,3–5 . 11 C-methionine uptake in inflammation has been reported in tumefactive demyelinaton, encephalitis (eg, Rasmussen syndrome, anti– N -methyl- d -aspartate receptor encephalitis), brain abscess, sarcoidosis, progressive multifocal leukoencephalopathy, tuberculoma, toxoplasma, progressive multifocal leukoencephalopathy, idiopathic hypertrophic cranial pachymeningitis, plasma cell granuloma, and more 2,4,6,7 . 11 C-methionine uptake in inflammation has been reported to involve increased metabolism and active amino acid transport as a result of increased density of inflammatory cells, as well as disruption of the brain-brain barrier 2,4,8 .…”